Search

Search Constraints

You searched for: Author/Creator Zichlin, Miriam L.

Search Results

2. Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 4‐year follow‐up and analysis of relative progression‐free survival from the randomized ELOQUENT‐2 trial. Issue 20 (11th September 2018)

4. Migraine-related healthcare resource use in the emergency department setting: a panel-based chart review in France, Germany, Italy, and Spain. (2nd September 2019)

5. Real-world clinical burden among patients with and without heart failure worsening after cardiac resynchronization therapy. (2nd September 2022)

6. Real-world healthcare resource utilization related to migraine treatment failure: a panel-based chart review in France, Germany, Italy, and Spain. (2nd September 2019)

7. Real-world migraine-related healthcare resource utilization and costs associated with improved vs. worsened/stable migraine: a panel-based chart review in France, Germany, Italy, and Spain. (1st January 2021)

8. S0655 The Incremental Rate of Thromboembolic Events in Patients With Inflammatory Bowel Disease Compared to Patients Without Immune-Mediated Diseases. (October 2020)

9. S0656 Risk Factors for Thromboembolic Events Among Patients With Immune-Mediated Diseases. (October 2020)

10. Treatment patterns and overall survival of patients with double-class and triple-class refractory multiple myeloma: a US electronic health record database study. Issue 2 (28th January 2023)